CNTB
NASDAQ · Biotechnology
Connect Biopharma Holdings L
$0.70
+0.01 (+1.44%)
Open$0.70
Previous Close$0.69
Day High$0.72
Day Low$0.67
52W High$3.82
52W Low$0.71
Volume—
Avg Volume715.3K
Market Cap45.89M
P/E Ratio—
EPS$-1.20
SectorBiotechnology
Analyst Ratings
Strong Buy
14 analysts
Price Target
+2,842.2% upside
Current
$0.70
$0.70
Target
$20.56
$20.56
$15.18
$20.56 avg
$23.56
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 62.9K | 69.44M | 70.73M |
| Net Income | -57,021,356 | 4.31M | 5.04M |
| Profit Margin | -86,687.5% | 6.2% | 7.1% |
| EBITDA | -58,960,585 | 5.85M | 6.49M |
| Free Cash Flow | — | 3.99M | 3.58M |
| Rev Growth | — | +2.8% | -4.7% |
| Debt/Equity | — | 0.90 | 0.87 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $295.03 | +0.20% | 49.3 | 509.50B |
| AMGN | Amgen Inc | $465.67 | -0.30% | 26.5 | 248.84B |
| GILD | Gilead Sciences Inc | $168.08 | +0.08% | — | 208.28B |
| VRTX | Vertex Pharmaceuticals Inc | $538.60 | -0.74% | 34.5 | 137.12B |
| REGN | Regeneron Pharmaceuticals | $955.47 | +0.45% | 19.4 | 93.39B |
| ALNY | Alnylam Pharmaceuticals Inc | $165.04 | +5.36% | 7.7 | 20.98B |